Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Interleukin-2 × NET × 1 year × Clear all

Sponsor

Cancer Type

Dermatologic 20 Thoracic 12 Other hematologic neoplasm 11 Lymphoid 11 Gynecologic 9 Gastrointestinal 9 Other solid neoplasm 6 Head & Neck 6 Genitourinary 5 Breast 5 Sarcoma 3 Plasma cell 3 CNS 3 Myeloid 2 Tumor-Agnostic 1

Interventions

lutetium Lu 177 dotatate 29 Magnetic Resonance Spectroscopy 15 Everolimus 11 pembrolizumab 9 Specimen Handling 9 cabozantinib 7 Nivolumab 7 surufatinib 6 Octreotide 6 lenvatinib 5 gallium Ga 68 dotatate 5 Lutetium-177 5 Capecitabine 5 177Lu-octreotide, DOTA(0)-Tyr(3)- 5 olaparib 4 lanreotide 4 amino-acid, glucose, and electrolyte solution 4 X-Rays 4 Ipilimumab 4 Injections 4 Fluorodeoxyglucose F18 4 copper dotatate CU-64 3 atezolizumab 3 Temozolomide 3 Lutetium 3 Ga(III)-DOTATOC 3 Cyclophosphamide 3 Carboplatin 3 tislelizumab 2 pasireotide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡